Approval · Notice of Compliance 19911 · 2017
SHINGRIX: Notice of Compliance 19911
Issued October 13, 2017
A Notice of Compliance is Health Canada’s approval of a drug submission: a new drug, a new use or form, or a change to an approved one. The product itself is in the Drug Product Database, with its current status.
- Notice number
- 19911
- Date
- October 13, 2017
- Company
- Glaxosmithkline IncMississauga, Ontario, Canada
- Product type
- Biologic
- Submission
- New Drug Submission (NDS)
- Submission class
- New Active Substance (NAS)
Products in this notice
| Brand | DIN | Status today |
|---|---|---|
| SHINGRIX | 02468425 | Marketed |
Medicinal ingredients
- VARICELLA-ZOSTER VIRUS GLYCOPROTEIN E (GE) 50 MCG per 0.5ML